Xerava
Total Payments
$928,388
Transactions
3,788
Doctors
1,614
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $928,388 | 3,788 | 1,614 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $352,849 | 137 | 38.0% |
| Unspecified | $229,849 | 54 | 24.8% |
| Consulting Fee | $162,430 | 17 | 17.5% |
| Food and Beverage | $93,027 | 3,272 | 10.0% |
| Travel and Lodging | $74,034 | 131 | 8.0% |
| Education | $15,250 | 13 | 1.6% |
| Gift | $950.12 | 164 | 0.1% |
Payments by Type
General
$698,539
3,734 transactions
Research
$229,849
54 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Safety and PK Study of IV Eravacycline | Tetraphase Pharmaceuticals, Inc. | $166,602 | 0 |
| Assessment of the Physical Compatibility of Eravacycline with Select Intravenous Drugs During Simulated Y-site Administration | TETRAPHASE PHARMACEUTICALS, INC. | $43,160 | 0 |
| A Safety and PK Study of IV Eravacycline | TETRAPHASE PHARMACEUTICALS, INC. | $17,087 | 0 |
| In Vitro activity of Eravacycline against Clinical Strains from Brooklyn, NY Hospitals | Tetraphase Pharmaceuticals, Inc. | $3,000 | 0 |
Top Doctors Receiving Payments for Xerava — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Infectious Disease | Safety Harbor, FL | $7,921 | 27 |
| , M.D | Internal Medicine | Chicago, IL | $6,664 | 6 |
| , M.D | Student in an Organized Health Care Education/Training Program | Louisville, KY | $5,766 | 9 |
| , M.D | Infectious Disease | Victoria, TX | $5,212 | 21 |
| , M.D | Infectious Disease | Torrance, CA | $4,944 | 4 |
| , MD, MS | Internal Medicine | Omaha, NE | $4,575 | 20 |
| , MD | Infectious Disease | Newark, NJ | $4,541 | 12 |
| , MD | Pediatric Infectious Diseases | Chapel Hill, NC | $4,471 | 16 |
| , MD | Infectious Disease | Atlanta, GA | $4,454 | 14 |
| , MD | Infectious Disease | The Woodlands, TX | $4,330 | 18 |
| , MD | Infectious Disease | Cleveland, OH | $4,254 | 13 |
| , MD | Internal Medicine | Boston, MA | $4,217 | 3 |
| , M.D | Infectious Disease | Miami, FL | $3,443 | 6 |
| , M.D | Internal Medicine | Miami Beach, FL | $3,420 | 9 |
| , MD | Infectious Disease | Pasadena, CA | $3,107 | 6 |
| , M.D | Infectious Disease | Boston, MA | $3,083 | 6 |
| , MD | Surgery | Pasadena, CA | $3,003 | 1 |
| , M.D | Infectious Disease | Houston, TX | $2,929 | 12 |
| , MD | Surgery | Charlotte, NC | $2,827 | 7 |
| , MD | Surgical Critical Care | Baltimore, MD | $2,542 | 6 |
| , MD, MS | Surgery | Charleston, SC | $2,533 | 4 |
| , MD | Infectious Disease | Dallas, TX | $2,302 | 9 |
| , M.D | Surgical Critical Care | Fort Worth, TX | $2,293 | 7 |
| , M.D | Transplant Surgery | Kalamazoo, MI | $2,275 | 3 |
| , M.D | Surgery | New York, NY | $2,275 | 3 |
Ad
Manufacturing Companies
- TETRAPHASE PHARMACEUTICALS, INC. $758,786
- Tetraphase Pharmaceuticals, Inc. $169,602
Product Information
- Type Drug
- Total Payments $928,388
- Total Doctors 1,614
- Transactions 3,788
About Xerava
Xerava is a drug associated with $928,388 in payments to 1,614 healthcare providers, recorded across 3,788 transactions in the CMS Open Payments database. The primary manufacturer is TETRAPHASE PHARMACEUTICALS, INC..
Payment data is available from 2019 to 2019. In 2019, $928,388 was paid across 3,788 transactions to 1,614 doctors.
The most common payment nature for Xerava is "Honoraria" ($352,849, 38.0% of total).
Xerava is associated with 4 research studies, including "A Safety and PK Study of IV Eravacycline" ($166,602).